ProQR Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRQR and other ETFs, options, and stocks.About PRQR
ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J.
CEODaniel Anton de Boer
CEODaniel Anton de Boer
Employees166
Employees166
HeadquartersLeiden, Zuid-Holland
HeadquartersLeiden, Zuid-Holland
Founded2012
Founded2012
Employees166
Employees166
PRQR Key Statistics
Market cap229.36M
Market cap229.36M
Price-Earnings ratio-6.26
Price-Earnings ratio-6.26
Dividend yield—
Dividend yield—
Average volume480.12K
Average volume480.12K
High today$2.20
High today$2.20
Low today$2.09
Low today$2.09
Open price$2.13
Open price$2.13
Volume175.65K
Volume175.65K
52 Week high$4.62
52 Week high$4.62
52 Week low$1.07
52 Week low$1.07
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own PRQR. This list is generated using Robinhood data, and it’s not a recommendation.